Literature DB >> 10527893

Interactions between Candida albicans and the human extracellular matrix component tenascin-C.

J L López-Ribot1, J Bikandi, R S San Millán, W L Chaffin.   

Abstract

Tenascins are large multimeric proteins that contain repeated structural motifs that include epidermal growth factor (EGF)-like repeats, fibronectin type III repeats and a globular fibrinogen-like domain, and are involved in tissue and organ morphogenesis, as well as in adhesion and migration of cells. C. albicans germ-tubes, but not blastospores, were able to bind to soluble human tenascin-C as revealed by an indirect immunofluorescence assay. However, materials present in cell wall extracts from both morphologies attached to tenascin-C immobilized in wells of a microtiter plate. The binding specificity was demonstrated by the inhibitory effect of antibodies against C. albicans cell wall components and an anti-tenascin antibody, but not anti-laminin antibody. Fibronectin, but not fibrinogen, inhibited binding, thus indicating a role of the fibronectin type III repeats in the interaction between the fungus and tenascin-C. Binding of C. albicans cell wall materials to tenascin was RGD- and divalent cation-independent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527893     DOI: 10.1006/mcbr.1999.0152

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  3 in total

Review 1.  Chaperonin 60 unfolds its secrets of cellular communication.

Authors:  Maria Maguire; Anthony R M Coates; Brian Henderson
Journal:  Cell Stress Chaperones       Date:  2002-10       Impact factor: 3.667

Review 2.  Candida albicans cell wall proteins.

Authors:  W LaJean Chaffin
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

3.  Involvement of fungal cell wall components in adhesion of Sporothrix schenckii to human fibronectin.

Authors:  O C Lima; C C Figueiredo; J O Previato; L Mendonça-Previato; V Morandi; L M Lopes Bezerra
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.